Cite
Impact of glycemic variability on the occurrence of periprocedural myocardial infarction and major adverse cardiovascular events (MACE) after coronary intervention in patients with stable angina pectoris at 6 months follow-up.
MLA
Xia, Jinggang, et al. “Impact of Glycemic Variability on the Occurrence of Periprocedural Myocardial Infarction and Major Adverse Cardiovascular Events (MACE) after Coronary Intervention in Patients with Stable Angina Pectoris at 6 Months Follow-Up.” Clinica Chimica Acta, vol. 471, Aug. 2017, pp. 196–200. EBSCOhost, https://doi.org/10.1016/j.cca.2017.06.014.
APA
Xia, J., Xu, J., Hu, S., Hao, H., Yin, C., & Xu, D. (2017). Impact of glycemic variability on the occurrence of periprocedural myocardial infarction and major adverse cardiovascular events (MACE) after coronary intervention in patients with stable angina pectoris at 6 months follow-up. Clinica Chimica Acta, 471, 196–200. https://doi.org/10.1016/j.cca.2017.06.014
Chicago
Xia, Jinggang, Ji Xu, Shaodong Hu, Hengjian Hao, Chunlin Yin, and Dong Xu. 2017. “Impact of Glycemic Variability on the Occurrence of Periprocedural Myocardial Infarction and Major Adverse Cardiovascular Events (MACE) after Coronary Intervention in Patients with Stable Angina Pectoris at 6 Months Follow-Up.” Clinica Chimica Acta 471 (August): 196–200. doi:10.1016/j.cca.2017.06.014.